Amyloidosis in juvenile chronic polyarthritis

Time to first and sustained improvement in WOMAC domains among patients with osteoarthritis receiving tanezumab.

Osteoarthritis and cartilage open·2022

Bone fragility after spinal cord injury: reductions in stiffness and bone mineral at the distal femur and proximal tibia as a function of time.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2018

CGRP blockade by galcanezumab was not associated with reductions in signs and symptoms of knee osteoarthritis in a randomized clinical trial.

Osteoarthritis and cartilage·2018

Efficacy and safety of single-dose onabotulinumtoxinA in the treatment of symptoms of osteoarthritis of the knee: results of a placebo-controlled, double-blind study.

Osteoarthritis and cartilage·2018

The Emotional Brain as a Predictor and Amplifier of Chronic Pain.

Journal of dental research·2016

The effects of proton pump inhibition on patient-reported severity of dyspepsia when receiving dual anti-platelet therapy with clopidogrel and low-dose aspirin: analysis from the Clopidogrel and the Optimization of Gastrointestinal Events Trial.

Alimentary pharmacology & therapeutics·2015

Regional distribution of adult rheumatologists.

Arthritis and rheumatism·2013

Clinically significant renal involvement in primary Sjögren's syndrome: clinical presentation and outcome.

Arthritis and rheumatism·2013

Headache in systemic lupus erythematosus: results from a prospective, international inception cohort study.

Arthritis and rheumatism·2013

Association of low baseline levels of erythrocyte folate with treatment nonresponse at three months in rheumatoid arthritis patients receiving methotrexate.

Arthritis and rheumatism·2013

2013 classification criteria for systemic sclerosis: an American College of Rheumatology/European League against Rheumatism collaborative initiative.

Arthritis and rheumatism·2013

Most patients with cancer-associated dermatomyositis have antibodies to nuclear matrix protein NXP-2 or transcription intermediary factor 1γ.

Arthritis and rheumatism·2013

Related Experiment Videos

Amyloidosis in juvenile chronic polyarthritis

Related Concept Videos

Time to first and sustained improvement in WOMAC domains among patients with osteoarthritis receiving tanezumab.

Bone fragility after spinal cord injury: reductions in stiffness and bone mineral at the distal femur and proximal tibia as a function of time.

CGRP blockade by galcanezumab was not associated with reductions in signs and symptoms of knee osteoarthritis in a randomized clinical trial.

Efficacy and safety of single-dose onabotulinumtoxinA in the treatment of symptoms of osteoarthritis of the knee: results of a placebo-controlled, double-blind study.

The Emotional Brain as a Predictor and Amplifier of Chronic Pain.

The effects of proton pump inhibition on patient-reported severity of dyspepsia when receiving dual anti-platelet therapy with clopidogrel and low-dose aspirin: analysis from the Clopidogrel and the Optimization of Gastrointestinal Events Trial.

Regional distribution of adult rheumatologists.

Clinically significant renal involvement in primary Sjögren's syndrome: clinical presentation and outcome.

Headache in systemic lupus erythematosus: results from a prospective, international inception cohort study.

Association of low baseline levels of erythrocyte folate with treatment nonresponse at three months in rheumatoid arthritis patients receiving methotrexate.

2013 classification criteria for systemic sclerosis: an American College of Rheumatology/European League against Rheumatism collaborative initiative.

Most patients with cancer-associated dermatomyositis have antibodies to nuclear matrix protein NXP-2 or transcription intermediary factor 1γ.

Related Experiment Videos

Amyloidosis in juvenile chronic polyarthritis

Related Concept Videos

Related Articles